
Development of Functional Antibodies Directed to Human Dialyzable Leukocyte Extract (Transferon®).

Development of Functional Antibodies Directed to Human Dialyzable Leukocyte Extract (Transferon®).
Fecha de publicación: 16 mayo de 2019 Development of Functional Antibodies Directed to Human Dialyzable Leukocyte Extract Transferon®) Ver...
An international comparative analysis and roadmap to sustainable biosimilar markets. VER MÁS
Progress and Challenges in the Design and Clinical Development of Antibodies for Cancer Therapy. VER MÁS
Fecha de publicación: Marzo 2021 Poor survival in COVID-19 associated with Lymphopenia and Higher Neutrophile-Lymphocyte ratio Ver más
Fecha de publicación: 10 de abril de 2019 CD80 Expression Correlates with IL-6 Production in THP-1-Like Macrophages Costimulated with...
CD80 Expression Correlates with IL-6 Production in THP-1-Like Macrophages Costimulated with LPS and Dialyzable Leukocyte Extract (Transferon®). VER MÁS
Regulatory Pathway for Licensing Biotherapeutics in Mexico. VER MÁS
Colloids and Surfaces A: Physicochemical and Engineering Aspects. Structural and physicochemical characteristics of one-step PAMAM dendrimeric nanoparticles. VER MÁS

+52 (55) 5729 6000 Ext. 62543
Escuela Nacional de Ciencias Biológicas. Prolongación de Carpio y Plan de Ayala S/N, Del. Miguel Hidalgo, CDMX, C.P. 11340.
©2026 UDIBI